Tranexamic acid

Generic Name
Tranexamic acid
Brand Names
Cyklokapron, Lysteda
Drug Type
Small Molecule
Chemical Formula
C8H15NO2
CAS Number
1197-18-8
Unique Ingredient Identifier
6T84R30KC1
Background

Tranexamic acid is a synthetic derivative of lysine used as an antifibrinolytic in the treatment and prevention of major bleeding. It possesses a similar mechanism of action to aminocaproic acid but is approximately 10-fold more potent.

It was first patented in 1957 and received its initial US approval in 1986.

Indication

Taken orally, tranexamic acid is indicated for the treatment of hereditary angioedema, cyclic heavy menstrual bleeding in premenopausal females, and other instances of significant bleeding in the context of hyperfibrinolysis. Given intravenously, tranexamic acid is indicated for short-term use (2-8 days) in patients with hemophilia to prevent or reduce bleeding following tooth extraction.

Associated Conditions
Bleeding, Heavy Menstrual Bleeding, Hereditary Angioedema (HAE)
Associated Therapies
-

Ulipristal Use in Chinese Population

First Posted Date
2016-07-07
Last Posted Date
2020-04-09
Lead Sponsor
Queen Mary Hospital, Hong Kong
Target Recruit Count
31
Registration Number
NCT02825719
Locations
🇭🇰

Department of Obstetrics and Gynaecology, Queen Mary Hospital, Hong Kong, Hong Kong

Perioperative Administration of Tranexamic Acid for Placenta Previa and Accreta Study

First Posted Date
2016-06-20
Last Posted Date
2019-12-03
Lead Sponsor
University of California, San Francisco
Target Recruit Count
14
Registration Number
NCT02806024
Locations
🇺🇸

Community Regional Medical Center, Fresno, California, United States

Effectiveness of Tranexamic Acid When Used as an Adjunct to Misoprostol for the Treatment of Postpartum Hemorrhage

First Posted Date
2016-06-20
Last Posted Date
2018-02-19
Lead Sponsor
Gynuity Health Projects
Target Recruit Count
260
Registration Number
NCT02805426
Locations
🇻🇳

Hung Vuong Hospital, Ho Chi Minh City, Vietnam

🇸🇳

Centre hospitalier Régional de Thiès, Ahmadou Sakhir Ndiéguène, Thiès, Senegal

🇻🇳

National OB-GYN Hospital, Hanoi, Vietnam

and more 1 locations

Efficacy of Tranexamic Acid in Hemoptysis

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-05-24
Last Posted Date
2016-05-24
Lead Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Target Recruit Count
66
Registration Number
NCT02781597
Locations
🇮🇳

Post graduate institute of medical education and research, Chandigarh, UT, India

Role of Tranexamic Acid Versus Uterine Cooling at Caesarean Section

First Posted Date
2016-05-23
Last Posted Date
2016-09-05
Lead Sponsor
Talkha Central Hospital
Target Recruit Count
100
Registration Number
NCT02780245
Locations
🇪🇬

Talkha Central Hospital, Mansoura, Al-Dakahliya, Egypt

Clinical Study to Assess the Equivalence of Tranexamic Acid vs Oxytocin in Reducing the PPH

Phase 3
Completed
Conditions
Interventions
First Posted Date
2016-05-18
Last Posted Date
2024-02-08
Lead Sponsor
Azienda U.S.L. 1 di Massa e Carrara
Target Recruit Count
256
Registration Number
NCT02775773
Locations
🇮🇹

Department of Ostetricia e Ginecologia-Ospedale delle Apuane, Massa, MS, Italy

TXA Study in Major Burn Surgery

First Posted Date
2016-04-28
Last Posted Date
2021-08-23
Lead Sponsor
Spectrum Health Hospitals
Target Recruit Count
25
Registration Number
NCT02753816
Locations
🇺🇸

Spectrum Health Hospital, Grand Rapids, Michigan, United States

Role Of Different Prophylactic Doses Of Intravenous Tranexamic Acid In Reducing Blood Loss At Caesarean Section

First Posted Date
2016-04-15
Last Posted Date
2016-06-15
Lead Sponsor
Talkha Central Hospital
Target Recruit Count
200
Registration Number
NCT02739815
Locations
🇪🇬

Al-Azhar University, Faculty of Medicine for Boys ( Cairo ), Al-Hussein University Hospital, Cairo, Egypt

Effects of Tranexamic Acid on Blood Loss and Transfusion Requirement Following Hip Fracture

Not Applicable
Conditions
Interventions
First Posted Date
2016-04-14
Last Posted Date
2016-04-14
Lead Sponsor
Rothman Institute Orthopaedics
Registration Number
NCT02738073
Locations
🇺🇸

Bryn Mawr Hospital, Bryn Mawr, Pennsylvania, United States

Intravenous Tranexamic Acid Versus Pericervical Tourniquet To Decrease Blood Loss In Trans-Abdominal Myomectomy

First Posted Date
2016-04-12
Last Posted Date
2016-04-12
Lead Sponsor
Ain Shams Maternity Hospital
Target Recruit Count
70
Registration Number
NCT02733952
Locations
🇪🇬

Ain shams university maternity hospital, Cairo, Egypt

© Copyright 2024. All Rights Reserved by MedPath